Navigation Links
New guidance on making work less of a pain in the back

New guidance for employers, patients and doctors on helping people with back pain return to work will be announced on Tuesday May 5 at the University of Leicester.

It is estimated that it costs society in excess of 12 billion a year with people taking time off work because of back pain. Around 80% of these costs, were not associated with healthcare but due to lost work production and associated wage replacement benefits.

"These figures demonstrate the importance of maintaining people with chronic pain in useful employment," says Professor Paul Watson of the University of Leicester Department of Health Sciences who was among a group of researchers investigating back pain and its impact in the workplace.

"The role of healthcare practitioners in sanctioning work absence has been investigated and this has demonstrated that the health service is currently ill equipped to manage work loss in people with chronic pain and may in itself contribute to the high societal costs."

The reasons why people become disabled by chronic pain are not entirely explained by the severity of pain or the pathology but are better explained by the interaction of complex psychological and societal factors. Treatments which ignore these factors risk perpetuating the problem of chronic disability and work loss.

Professor Watson will present his report at the University of Leicester on Tuesday 5 May at 5.30pm. The lecture takes place in the Ken Edwards Building, Lecture Theatre 1 and is open to the public and free.

Key recommendations are:

  • Assessment of the key, psychosocial barriers to successful rehabilitation
  • Development of an action plan to provide comprehensive treatment to address these barriers.
  • A co-ordinated approach involving of healthcare workers, employers and patients to prevent work loss
  • A recognition that a return to full engagement in society, including work, is beneficial to health of those with chronic pain.

Following the lecture, an evidence based guide for clinicians, patients and employers on how to help people with chronic pain remain in work will be published. This was funded by a group including clinical interest groups, employers and health insurance companies. It will be made available as a free PDF.

Professor Watson said: "This work is extremely topical. The Chief Medical Officer has just released a report identifying the need to improve the management of pain. Dame Carol Black has launched an initiative to try and return people with chronic health problems to work - much of what she recommends is included in our evidence based review and underpins our previous research in this area over the last six years.

"The University of Leicester has been instrumental in performing key research on returning unemployed people with chronic pain to work and we have written a number of reports on the barriers and bridges to employment in this group.

"We are currently conducting research in how healthcare services can be made more effective in assisting people to remain in work by educating GPs on returning people with back pain to work - the results of this work will not be out until next year."


Contact: University of Leicester Press Office
University of Leicester

Related medicine news :

1. Cardinal Health Reaffirms Fiscal 2008 EPS Guidance, Updates Segment Profit Outlook
2. QMed, Inc. Comments on Estimated 3rd Quarter Results & Medical Expense Ratio; Sets 2008 Revenue Guidance for Medicare SNPs at $88-95 Million
3. Natural Alternatives International, Inc. Announces Late Filing of its Annual Report on Form 10-K, Revenue for Fiscal 2007 and Guidance on First Quarter of Fiscal 2008
4. West Pharmaceutical Services Updates Annual Guidance
5. Medifast Announces Updated Full Year 2007 Guidance
6. Isis Favorably Revises Financial Guidance and Introduces Mipomersen as Generic Name for ISIS 301012
7. Bradmer provides Phase III Neuradiab trial update and guidance
8. QLT announces Visudyne(R) sales for third quarter and provides Visudyne sales guidance for 2007
9. Sanofi-aventis Announces a Good Third Quarter Performance; Increase in 2007 full-year earnings growth guidance
10. Further Upgrade to 2007 Financial Guidance Based on Strong Revenue Growth; VYVANSE Demand on Track
11. Otter Tail Corporation Announces Third Quarter Earnings and Maintains 2007 Earnings Guidance; Board of Directors Declares Dividend
Post Your Comments:
(Date:11/30/2015)... ... November 30, 2015 , ... Brenntag ... exclusive channel partner for the Nutraceutical Specialties products into oral solid dosage in ... immediately. , “We are pleased to announce our expanded distribution agreement with ...
(Date:11/30/2015)... , ... November 30, 2015 , ... An inventor from ... in the womb. "My last baby had high blood pressure due to loud noises," ... to protect their babies from noise pollution as well as radio waves and microwaves." ...
(Date:11/30/2015)... ... November 30, 2015 , ... Since its inception, ... in independent living, assisted living and all other retirement options. Support for issues ... and research remains a top priority. , So it’s no surprise that ...
(Date:11/30/2015)... ... 30, 2015 , ... Sikka Software announced today that they are showcasing the ... to make complex business decisions by providing the tools and information they need to ... with 10 procedures customized by zip code. , The Sikka Software Ecosystem includes ...
(Date:11/30/2015)... (PRWEB) , ... November 30, 2015 , ... ... the assets of DataTrade Solutions Inc., a Healthcare IT consulting, development and support ... the programming and technical experience available within DataTrade to extend the services currently ...
Breaking Medicine News(10 mins):
(Date:11/27/2015)... NEW YORK , November 27, 2015 ... health system is set to go online. The potential ... and processes is vast and far from fully exploited ... access to patient health records, either via mobile tablet ... ) --> ) ...
(Date:11/27/2015)... PHILADELPHIA , Nov. 27, 2015  Lannett ... that it has completed the acquisition of Kremers ... pharmaceuticals subsidiary of global biopharmaceuticals company UCB S.A. ... --> Lannett has acquired KU from UCB ... to certain adjustments, including a customary working capital ...
(Date:11/27/2015)... 2015 ... "2016 Global Tumor Marker Testing Market: ... Sales Segment Forecasts, Innovative Technologies, Instrumentation Review, ... their offering. --> ) ... "2016 Global Tumor Marker Testing Market: Supplier ...
Breaking Medicine Technology: